PUBLIC COMPANY
saveImmedica Pharma AB
updated 4mo ago
community read0 votes
🐶 often sniffed alongside
top 3pipeline
3
marketed
1
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Marketed2Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study of AEB1102 (Pegzilarginase) in Patients With Arginase 1 Deficiency
- phase1A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS
- phase3Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old
- phase3Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that